The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Sphingolipid Synthesis as a Target for Antifungal Drugs
Open accessAbstract
We have identified a Saccharomyces cerevisiae gene necessary for the step in sphingolipid synthesis in which inositol phosphate is added to ceramide to form inositol-P-ceramide, a reaction catalyzed by phosphatidylinositol:ceramide phosphoinositol transferase (IPC synthase). This step should be an effective target for antifungal drugs. A key element in our experiments was the development of a procedure for isolating mutants defective in steps in sphingolipid synthesis downstream from the first step including a mutant defective in IPC synthase. An IPC synthase defect is supported by data showing a failure of the mutant strain to incorporate radioactive inositol or N-acetylsphinganine into sphingolipids and, by using an improved assay, a demonstration that the mutant strain lacks enzyme activity. Furthermore, the mutant accumulates ceramide when fed exogenous phytosphingosine as expected for a strain lacking IPC synthase activity. Ceramide accumulation is accompanied by cell death, suggesting the presence of a ceramide-activated death response in yeast. A gene, AUR1 (YKL004w), that complements the IPC synthase defect and restores enzyme activity and sphingolipid synthesis was isolated. Mutations in AUR1 had been shown previously to give resistance to the antifungal drug aureobasidin A, leading us to predict that the drug should inhibit IPC synthase activity. Our data show that the drug is a potent inhibitor of IPC synthase with an IC50 of about 0.2 nM. Fungal pathogens are an increasing threat to human health. Now that IPC synthase has been shown to be the target for aureobasidin A, it should be possible to develop high throughput screens to identify new inhibitors of IPC synthase to combat fungal diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Basic local alignment search tool
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990) · Journal of Molecular Biology · doi:10.1006/jmbi.1990.9999 · Cited by 98,669
Sikorski, R. S., & Hieter, P. (1989) · Genetics · doi:10.1093/genetics/122.1.19 · Cited by 8,664
Improved method for high efficiency transformation of intact yeast cells
Gietz, D., Jean, A. S., Woods, R. A., & Schiestl, R. H. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.6.1425 · Cited by 3,261
Analysis of membrane and surface protein sequences with the hydrophobic moment plot
Eisenberg, D., Schwarz, E., Komaromy, M., & Wall, R. (1984) · Journal of Molecular Biology · doi:10.1016/0022-2836(84)90309-7 · Cited by 2,284
[19] Targeting, disruption, replacement, and allele rescue: Integrative DNA transformation in yeast
Rothstein, R. (1991) · Methods in Enzymology · doi:10.1016/0076-6879(91)94022-5 · Cited by 1,326
The detection and classification of membrane-spanning proteins
Klein, P., Kanehisa, M., & DeLisi, C. (1985) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(85)90375-x · Cited by 835
Bose, R., Verheij, M., Haimovitz-Friedman, A., Scotto, K., Fuks, Z., & Kolesnick, R. (1995) · Cell · doi:10.1016/0092-8674(95)90429-8 · Cited by 826
A conformational preference parameter to predict helices in integral membrane proteins
Mohana Rao, J. K., & Argos, P. (1986) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(86)90295-5 · Cited by 552
Alkaline O→N-transacylation. A new method for the quantitative deacylation of phospholipids
Clarke, N. G., & Dawson, R. M. C. (1981) · Biochemical Journal · doi:10.1042/bj1950301 · Cited by 318
[8] Putting the HO gene to work: Practical uses for mating-type switching
Herskowitz, I., & Jensen, R. E. (1991) · Methods in Enzymology · doi:10.1016/0076-6879(91)94011-z · Cited by 252
Cited by
Signal transduction of stress via ceramide
MATHIAS, S., PEÑA, L. A., & KOLESNICK, R. N. (1998) · Biochemical Journal · doi:10.1042/bj3350465 · Cited by 682
The biology and chemistry of antifungal agents: A review
Kathiravan, M. K., Salake, A. B., Chothe, A. S., Dudhe, P. B., Watode, R. P., Mukta, M. S., & Gadhwe, S. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.04.045 · Cited by 664
Identification of a family of animal sphingomyelin synthases
Huitema, K., van den Dikkenberg, J., Brouwers, J. F., & Holthuis, J. C. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600034 · Cited by 611
Homeoviscous Adaptation and the Regulation of Membrane Lipids
Ernst, R., Ejsing, C. S., & Antonny, B. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.08.013 · Cited by 506
“where the inositol-phosphate headgroup from PI molecules is transferred to ceramide to produce inositol-containing sphingolipids and DAG (the orthol ogous reac t i on i n mamma l s t r ans f e r s choline-phosphate from PC to produce sphingomyelin) [37].”
BackgroundEnzymes of Sphingolipid Metabolism: From Modular to Integrative Signaling
Hannun, Y. A., Luberto, C., & Argraves, K. M. (2001) · Biochemistry · doi:10.1021/bi002836k · Cited by 500
Physiology and pathophysiology of sphingolipid metabolism and signaling
Huwiler, A., Kolter, T., Pfeilschifter, J., & Sandhoff, K. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00042-1 · Cited by 432
Yeast lipid metabolism at a glance
Klug, L., & Daum, G. (2014) · FEMS Yeast Research · doi:10.1111/1567-1364.12141 · Cited by 349
Antifungal Peptides: Novel Therapeutic Compounds against Emerging Pathogens
De Lucca, A. J., & Walsh, T. J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.1.1 · Cited by 337
The Organizing Potential of Sphingolipids in Intracellular Membrane Transport
Holthuis, J. C. M., Pomorski, T., Raggers, R. J., Sprong, H., & Van Meer, G. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.4.1689 · Cited by 320
Flexibility of a Eukaryotic Lipidome – Insights from Yeast Lipidomics
Klose, C., Surma, M. A., Gerl, M. J., Meyenhofer, F., Shevchenko, A., & Simons, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035063 · Cited by 301
Plant sphingolipids: structural diversity, biosynthesis, first genes and functions
Sperling, P., & Heinz, E. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(03)00033-7 · Cited by 286
The Multigenic Sphingomyelin Synthase Family
Tafesse, F. G., Ternes, P., & Holthuis, J. C. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.r600021200 · Cited by 286
C26-CoA-dependent ceramide synthesis of Saccharomyces cerevisiae is operated by Lag1p and Lac1p
Guillas, I. (2001) · The EMBO Journal · doi:10.1093/emboj/20.11.2655 · Cited by 277
Schorling, S., Vallée, B., Barz, W. P., Riezman, H., & Oesterhelt, D. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.11.3417 · Cited by 276
Functions and metabolism of sphingolipids in Saccharomyces cerevisiae
DICKSON, R., SUMANASEKERA, C., & LESTER, R. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2006.03.004 · Cited by 265
Self-citationAntifungal Peptides as Therapeutic Agents
Fernández de Ullivarri, M., Arbulu, S., Garcia-Gutierrez, E., & Cotter, P. D. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00105 · Cited by 264
SPHINGOLIPID FUNCTIONS IN SACCHAROMYCES CEREVISIAE: Comparison to Mammals
Dickson, R. C. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.27 · Cited by 253
Self-citationThe Future of Antifungal Drug Therapy: Novel Compounds and Targets
Mota Fernandes, C., Dasilva, D., Haranahalli, K., McCarthy, J. B., Mallamo, J., Ojima, I., & Del Poeta, M. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01719-20 · Cited by 124
Natural products as antifungal agents against clinically relevant pathogens
Di Santo, R. (2010) · Natural Product Reports · doi:10.1039/b914961a · Cited by 115
Calcineurin-dependent contributions to fitness in the opportunistic pathogen Candida glabrata
Pavesic, M. W., Gale, A. N., Nickels, T. J., Harrington, A. A., Bussey, M., & Cunningham, K. W. (2024) · mSphere · doi:10.1128/msphere.00554-23 · Cited by 22
Metadata
- Authors
- Nagiec, M. M., Nagiec, E. E., Baltisberger, J. A., Wells, G. B., Lester, R. L., & Dickson, R. C.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1997-04
- Volume
- 272
- Issue
- 15
- Pages
- 9809-9817
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2066160116
- Cited by
- 391
- References
- 29
- FWCI
- 6.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.